Adamas Pharmaceuticals, Inc. Return on Tangible Equity 2014-2021 | ADMS
Current and historical return on tangible equity values for Adamas Pharmaceuticals, Inc. (ADMS) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2021-09-30 | $-0.06B | $-0.02B | 350.00% |
| 2021-06-30 | $-0.06B | $-0.01B | 258.82% |
| 2021-03-31 | $-0.05B | $0.01B | 207.69% |
| 2020-12-31 | $-0.06B | $-0.05B | 185.60% |
| 2020-09-30 | $-0.06B | $-0.04B | 331.58% |
| 2020-06-30 | $-0.08B | $-0.02B | 1504.76% |
| 2020-03-31 | $-0.09B | $-0.02B | -808.70% |
| 2019-12-31 | $-0.11B | $-0.00B | -336.51% |
| 2019-09-30 | $-0.11B | $0.02B | -206.45% |
| 2019-06-30 | $-0.12B | $0.04B | -150.48% |
| 2019-03-31 | $-0.13B | $0.06B | -122.63% |
| 2018-12-31 | $-0.13B | $0.09B | -101.35% |
| 2018-09-30 | $-0.13B | $0.11B | -106.29% |
| 2018-06-30 | $-0.12B | $0.14B | -104.09% |
| 2018-03-31 | $-0.11B | $0.17B | -101.41% |
| 2017-12-31 | $-0.09B | $0.07B | -94.68% |
| 2017-09-30 | $-0.08B | $0.09B | -67.87% |
| 2017-06-30 | $-0.07B | $0.10B | -52.80% |
| 2017-03-31 | $-0.06B | $0.12B | -45.01% |
| 2016-12-31 | $-0.06B | $0.13B | -40.13% |
| 2016-09-30 | $-0.06B | $0.14B | -38.49% |
| 2016-06-30 | $-0.06B | $0.16B | -40.57% |
| 2016-03-31 | $-0.05B | $0.17B | -39.85% |
| 2015-12-31 | $-0.05B | $0.12B | -40.55% |
| 2015-09-30 | $-0.03B | $0.12B | -24.26% |
| 2015-06-30 | $-0.03B | $0.14B | -20.25% |
| 2015-03-31 | $0.00B | $0.14B | 1.43% |
| 2014-12-31 | $0.01B | $0.15B | 6.48% |
| 2014-09-30 | $0.02B | $0.13B | 20.80% |
| 2014-06-30 | $0.03B | $0.14B | 40.00% |
| 2014-03-31 | $0.01B | $0.07B | 26.67% |
| 2013-12-31 | $0.03B | $0.08B | 178.95% |
